145
Views
21
CrossRef citations to date
0
Altmetric
Review

Camelpox: epidemiology, diagnosis and control measures

, , , , , & show all
Pages 1187-1201 | Published online: 10 Jan 2014

References

  • Azwai SM, Carter SD, Woldehiwet Z. Monoclonal antibodies against camel (Camelus dromedarius) IgG, IgM and light chains. Vet. Immunol. Immunopathol.45, 175–184 (1995).
  • OIE Manual. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 6th Edition. Volume 2, Chapter 2.7.14. OIE, France (2008).
  • Wernery U, Kaaden OR. Camel pox. In: Infectious Diseases in Camelids, Second Edition. Wernery U, Kaaden OR (Eds). Blackwell Science Berlin, Vienna, 176–185 (2002).
  • Leese S. Two diseases of young camels. J. Trop. Vet. Sci.4, 1 (1909).
  • Hafez SM, Al-Sukayran A, dela Cruz D et al. Development of a live cell culture camelpox vaccine. Vaccine8(10), 533–539 (1992).
  • Jezek Z, Kriz B, Rothbaur V. Camelpox and its risk to the human population. J. Hyg. Epi. Microbio. Immunol.27, 29–42 (1983).
  • Al-Ziabi O, Nishikawa H, Meyer H. The first outbreak of camelpox in Syria. J. Vet. Med. Sci.69(5), 541–543 (2007).
  • Davies FG, Mungai JN, Shaw T. Characteristics of a Kenyan camelpox virus. J. Hyg.7, 381–385 (1975).
  • Kriz B. A study of camelpox in Somalia. J. Comp. Pathol.92, 1–8 (1982).
  • ICTV. Virus Taxonomy: 8th Report of the International Committee on Taxonomy of Viruses. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. (Eds), 123, Academic Press (2005).
  • Mahnel H, Bartenbach G. Classification of camelpox virus (CPV). Zentralbl Veterinarmed B.20(7), 762–766 (1973).
  • Baxby D. Smallpox viruses from camels in Iran. Lancet7786, 1063–1065 (1972).
  • Fenner F, Wittek R, Dumbell KR. The Orthopoxviruses. Academic Press Inc., Harcourt Brace Jovanovich, NY, USA (1989).
  • Bedson HS. Camelpox and smallpox. Lancet2, 1253 (1972).
  • Baxby D. Differentiation of smallpox and camelpox viruses in cultures of human and monkey cells. J. Hyg.72, 251–254 (1974).
  • Esposito JJ, Knight JC. Orthopoxvirus DNA: a comparison of restriction profiles and maps. Virology143, 230–251 (1985).
  • Baxby D, Ramyar H, Hessami M, Ghaboosi B. A comparison of the response of camels to intradermal inoculation with camelpox and smallpox viruses. Infect. Immun.11, 617–621 (1975).
  • Gubser C, Smith GL. The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J. Gen. Virol.83(4), 855–872 (2002).
  • Sheikh Ali HM, Khalafalla AI, Nimir AH. Detection of camel pox and vaccinia viruses by polymerase chain reaction. Trop. Anim. Health. Prod.41(3), 393–396 (2009).
  • Afonso CL, Tulman ER, Lu Z et al. The genome of camelpox virus. Virology295(1), 1–9 (2002).
  • Borisovich YuF. Camel pox. Ospa verblyudov, Variola camelina. In: Maloizvestnye Zaraznye Bolezni Zhivotnykh (Little-Known Contagious Diseases of Animals) Orlov FM (Ed.). Izdatel’stvo Kolos, USSR, 2nd Edition, 32–42 (Ru) (1973).
  • Duraffour S, Snoeck R, Krecmerova M et al. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models. Antimicrob. Agents Chemother,51(12), 4410–4419 (2007).
  • Moss B. Poxviridae: the viruses and their replication. In: Field’s Virology, Fourth Edition. Knipe DM, Howley PM (Eds). Lippincott Williams and Wilkins, Philadelphia, PA, USA, 2849–2883 (2001).
  • Murphy FA, Gibbs, EPJ, Horzinek MC, Studdert MJ. Veterinary Virology. 3rd Edition. Academic Press, San Diego, CA, USA, 282 (1999).
  • Engelstad M, Smith GL. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egressof extracellular virus and for virus virulence. Virology194, 627–637 (1993).
  • Isaacs SN, Wolffe EJ, Payne LG, Moss B. Characterization of a vaccinia virus-encoded 42-kilodalton classI membrane glycoprotein component of the extracellular virus envelope. J. Virol.66, 7217–7224 (1992).
  • Martinez-Pomares L, Stern RJ, Moyer RW. The ps/hr gene (B5R open reading frame homolog) of rabbitpox virus controls pock color, is a component of extracellular enveloped virus, and is secreted into the medium. J. Virol.67, 5450–5462 (1993).
  • Balamurugan V, Bhanuprakash V, Hosamani M, Srinivasan VA, Singh RK. Comparative sequence analyses of B5R gene of Indian camelpox virus isolates with other orthopoxviruses. Indian J. Virol.19(20), 34–38 (2008).
  • Tantawi HH, Saban MS, Reda IM, El-Dahaby H. Camelpox virus in Egypt I – isolation and characterization. Bull. Epizoot. Dis. Africa.22(4), 315–319 (1974).
  • Al-Falluji MM, Tantawi HH, Shony MO. Isolation, identification and characterization of camelpox virus in Iraq. J. Hyg. Camb.83, 267–272 (1979).
  • Khalafalla AI, Mohamed MEH, Ali BH. Camel pox in the Sudan and its isolation and identification of the causative virus. J. Camel Pract. Res.5(2), 229–233 (1998).
  • Coetzer JAW. Poxviridae. In: Infectious Diseases of Livestock, Second Edition. Coetzer JAW, Tustin RC (Eds). Oxford University Press, Southern Africa, 2, 1265–1267 (2004).
  • Buchnev KN, Sadykov RG. On camelpox in Kazakhstan (in Russian 1. Tr. Nauchno-issledov). Vet. Instituta Alma-Ata15, 12 (1969).
  • Wilson RT, Araya A, Melaku A. The one humped camel. An analytical and annoated Bibliography 1980–1989. Animal Production and Health Section, Joint FAO/IAEA, Division for Nuclear Techniques in Food and Agriculture, Wien, Austria (1990).
  • Davies FG, Mbugua H, Atema C, Wilson A. The prevalence of antibody to camelpox virus in six different herds in Kenya. J. Comp. Path.95, 633–635 (1985).
  • Munz E, Kropp E, Reimann M. Demonstration of antibodies against Orthopoxvirus cameli in sera of East African dromedaries by ELISA. J. Vet. Med. B.3, 221–230 (1986).
  • Fassi-Fehri MM. Diseases of camels. Rev. Sci. Tech. Off. Int. Epiz.6, 337–354 (1987).
  • Ramyar H, Hessami M. Isolation, cultivation and characterisation of camelpox virus. Zentralblatt fur Veterinarmedizin.19(3), 182–189 (1972).
  • Higgins AJ, Silvey RE, Abdelghafir AE, Kitching RP. The epidemiology and control of an outbreak of camelpox in Bahrain. Proc. 1st. Int. Camel Conf.101–104 (1992).
  • Kaaden OR, Walz A, Czerny CP, Wernery U. Progress in the development of a camelpox vaccine. Proc. 1st. Int. Camel Conf.47–49 (1992).
  • Al Hendi AB, Abuelzein EM, Gameel AA, Hassanein MM. A slow-spreading mild form of camelpox infection. J. Vet. Med. B.41, 71–73 (1994).
  • Marrenikova SS, Shenkman LS, Shelukhina EM, Malsova NN. Isolation of camelpox virus and investigation of its properties. Acta Virol.18, 423–428 (1974).
  • Chauhan RS, Kaushik RK. Isolation of camelpox virus in India. Br. Vet. J.143, 581–582 (1987).
  • Pfahler WHE, Munz E. Camelpox. Int. J. Anim. Sci.4, 109–114 (1989).
  • Hafez SM, Eissa YM, Amjad AM, Al-Sharif AK, Al-Sukayran A, dela Cruz D. Preliminary studies on camelpox in Saudi Arabia. In: Programme and Abstracts of the 9th Symposium on the Biological Aspects of Saudi Arabia, Riyadh. March (1986).
  • Abu Alzein EM, Gameel AA, Ramadan RO, Housawi FM. An eruptive moderate form of camelpox infection in dromedary camels (Camelus dromedarius) in Saudi Arabia. Rev. Sci. Tech.18, 749–752 (1999).
  • Al-Ani MOA, Al-Salihy RA. Camelpox in Iraq. Bull. Anim. Hlth. Prod. Afr.36, 394–397 (1988).
  • Hussein MF, Al-Mufarrej SL. Some clinicopathological aspects of camelpox in Saudi Arabia. J. king. Saud. Univ., Agric. Sci.11(2), 113–120 (1999).
  • Ommer Dafalla MA, Abdelhamid Elfadil AM. Epidemiologic and clinical features of camelpox in Jazan region, Saudi Arabia. Vet. Res.1(3), 65–67 (2007).
  • Pfeffer M, Meyer H, Wernery U, Kaaden OR. Comparison of camelpox viruses isolated in Dubai. Vet. Microbiol.49, 135–146 (1996).
  • Odend’Hal S. The Geographical Distribution of Animal Viral Diseases. Academic Press, NY, USA, 99 (1983).
  • Chauhan RS, Kulshreshtha RC, Kaushik RK. Epidemiological studies of viral diseases of livestock in Haryana State. Ind. J. Virol.1(1), 10–16 (1985).
  • Chauhan RS, Kaushik RK, Gupta SC, Satiya KC, Kulshreshtha RC. Prevalence of differential diseases in camels (Camelus dromedaries) in India. Camel New letter3, 10–14 (1986).
  • Khanna ND, Uppal PK, Sharma N, Tripathi BN. Occurrence of pox infections in camels. Ind. Vet. J.73(8), 813–817 (1996).
  • Renner-Muller IC, Meyer H, Munz E. Characterization of camelpox virus isolates from Africa and Asia. Vet. Microbio.45, 371–381 (1995).
  • Schwartz, Sabine, Schwartz HJ, Wilson AJ. Eine fotographische Dokumentation wishtiger Kamelkrankheiten in Kenia. Der. Prakt. Tierarzt.11, 985–989 (1982).
  • Kropp EM. Kamelpocken – eine synoptische Darstellung sowie der Nachweis von Antikorpern in ostafrikanischen Dromedarseren mit einem ELISA. Vet. Med. Diss. Munchen, Germany (1985).
  • Gitao CG. An investigation of camelpox outbreaks in two principal camel (Camelus dromedarius) rearing areas of Kenya. Rev. Sci. Tech.16, 841–847 (1997).
  • Richard D. Manuel des maladies du dromadaire. Projet de derveloppement de l’elevage dans le Niger centre-est. Maisons Alfort, IEMVT (1986).
  • Nguyen-ba-vy, Richard D, Gillet JP. Characterization of an orthopoxvirus of camels from Niger. Rev. Elev. Med. Vet. Pays Trop.42, 19–25 (1989).
  • Shommein AM, Osman AM. Diseases of camels in the Sudan. Rev. Sci. Tech. Off. Int. Epiz.6, 481–484 (1987).
  • Roslyakov AA. Comparative ultrastructure of camelpox virus, the virus of a pox-like disease of camels (‘auzdyk’) and contagious ecthyma virus. Vopr. Virusol.17, 26–30 (1972).
  • Buchnev KN, Tulepbaev SZ, Sansyzbaev AR. Infectious diseases of camels in the USSR. Revue. Sci. Tech.6, 487–495 (1987).
  • Champak Bhakat, Chaturvedi D, Raghavendra S, Nagpaul PK. Studies on camel management under various microenvironment of shelter systems. Indian J. Dairy Sci.57(5), 347–353 (2004).
  • Azwai SM, Carter SD, Woldehiwet Z, Wernery U. Serology of Orthopoxvirus cameli infection in dromedary camels: analysis by ELISA and western blotting. Comp. Immunol. Microbiol. Infect. Dis.19(1), 65–78 (1996).
  • Khalafalla AI, Mohamed MEH, Agab H. Serological survey in camels of the Sudan for prevalence of antibodies to camelpox virus using ELISA technique. J. Camel Pract. Res.5(2), 197–200 (1998).
  • Mayer A, Czerny CP. Camelpox virus. In: Virus Infections of Vertebrates. Vol. 3, Virus Infections of Ruminants, Dinter Z. Morein B (Eds). Elsevier Science Publisher BV, Amsterdam, Oxford, New York, Tokyo, 19–22 (1990).
  • Nothelfer HB, Wernery U, Czerny CP. Camel pox: antigen detection within skin lesions – immunohistochemistry as a simple method of etiological diagnosis. J. Camel Pract. Res.2(2), 119–121 (1995).
  • Wernery U, Kaaden OR, Ali M. Orthopox virus infections in dromedary camels in United Arab Emirates (U.A.E.) during winter season. J. Camel Pract. Res.4(1), 51–55 (1997).
  • Wernery U, Meyer H, Pfeffer M. Camel pox in the United Arab Emirates and its prevention. J. Camel Pract. Res.4(2), 135–139 (1997).
  • Bhanuprakash V, Balamurugan V, Hosamani M et al. Isolation and characterization of Indian isolates of camel pox virus. Trop. Anim. Health Prod. DOI: 10.1007/s11250-010-9560-z (2010) (Epub ahead of print).
  • Khalfalla AI, Mohamed MEM. Camel pox in the Sudan. J. Camel Prac. Res.5(2), 235–238 (1998).
  • Borisovich YF, Orekhov MD. Camel pox. Veterinariya (Moscow)3, 50–52 (1966).
  • Khalafalla AI, Mohamed MEH. Clinical and epizootiological features of camelpox in eastern Sudan. J. Camel Prac. Res. (2), 99–102 (1996).
  • Pfeffer M, Neubauer H, Wernery U, Kaaden OR, Meyer H. Fatal form of camelpox virus infection. Vet. J.155, 107–109 (1998).
  • Yager JA, Scott DW, Wilcock BP. Viral diseases of the skin. In: Pathology of Domestic Animals, Fourth Edition. Jubb KVF, Kennedy PC, Palmer N (Eds). Academic Press, San Diego, USA, 629–644 (1991).
  • Kinne J, Cooper JE, Wernery U. Pathological studies on camelpox lesions of the respiratory system in the United Arab Emirates (UAE). J. Comp. Pathol.118, 257–266 (1998).
  • Wernery U, Zachariah R. Experimental camel pox infection in vaccinated and unvaccinated dromedaries. J. Vet. Med. [B] Infect. Dis.46(2), 131–136 (1999).
  • Khalafalla AI, El Dirdiri GA. Laboratory and field investigations of a live attenuated and an inactivated camelpox vaccine. J. Camel Prac. Res.10(2), 191–200 (2003).
  • Najarro P, Traktman P, Lewis JA. Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J. Virol.75(7), 3185–3196 (2001).
  • Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O’Neill LA. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl Acad. Sci. USA97(18), 10162–10167 (2000).
  • Moss B, Shisler JL. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol.13(1), 59–66 (2001).
  • Perkus ME, Goebel SJ, Davis SW et al. Vaccinia virus host range genes. Virology179(1), 276–286 (1990).
  • Kotwal GJ, Hugin AW, Moss B. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13800-Da secreted protein. Virology171(2), 579–587 (1989).
  • Betakova T, Wolffe EJ, Moss B. The vaccinia virus A14.5L gene encodes a hydrophobic 53-amino-acid virion membrane protein that enhances virulence in mice and is conserved among vertebrate poxviruses. J. Virol.74(9), 4085–4092 (2000).
  • Barry M, Hnatiuk S, Mossman K, Lee SF, Boshkov L, McFadden G. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology239(2), 360–377 (1997).
  • Senkevich TG, Wolffe EJ, Buller RML. Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J. Virol.69(7), 4103–4111 (1995).
  • Mossman K, Lee SF, Barry M, Boshkov L, McFadden G. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol.70, 4394–4410 (1996).
  • Alcami A, Smith GL. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol.69, 4633–4639 (1995).
  • Symons JA, Alcami A, Smith GL. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell81, 551–560 (1995).
  • Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol.160, 624–633 (1998).
  • Alcami A, Khanna A, Paul NL, Smith GL. Vaccinia virus strains Lister, USSR and Evans express soluble and cell surface tumour necrosis factors receptor. J. Gen. Virol.80, 949–959 (1999).
  • Blomquist MC, Hunt LT, Barker WC. Vaccinia virus 19-kilodalton protein: relationship several mammalian proteins, including two growth factors. Proc. Natl Acad. Sci. USA81, 7363–7367 (1984).
  • Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science250, 827–830 (1990).
  • Turner PC, Musy PY, Moyer RW. Poxvirus serpins. In: Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. McFadden G (Ed.). RG Landes, TX, USA, 67–88 (1995).
  • Smith GL, Symons JA, Alcami A. Poxviruses; interfering with interferon. Semin. Virol.8, 409–418 (1998).
  • Walter L, Marynen P, Szpirer J, Levan G, Gunther E. Identification of a novel conserved human gene, TEGT. Genomics28, 301–304 (1995).
  • Kumar KN, Tilakaratne N, Johnson PS, Allen AE, Michaelis EK. Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex. Nature354, 70–73 (1991).
  • Xu Q, Reed JC. Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Molecular Cell1, 337–346 (1998).
  • Kawai M, Pan L, Reed JC, Uchimiya H. Evolutionally conserved plant homologue of the Bax inhibitor-1 (BI-1) gene capable of suppressing Bax-induced cell death in yeast(1). FEBS Letters464, 143–147 (1999).
  • Schwarz DA, Katayama CD, Hedrick SM. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity9, 657–668 (1998).
  • Shchelkunov SN, Safronov PF, Totmenin AV et al. The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology243, 432–460 (1998).
  • Eskra L, Mathison A, Splitter G. Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect. Immun.71, 1125–1133 (2003).
  • Geserick P, Kaiser F, Klemm U, Kaufmann SH, Zerrahn J. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Int. Immunol.16, 1535–1548 (2004).
  • Alcami A, Symons JA, Khanna A, Smith GL. Poxviruses: capturing cytokines and chemokines. Semin. Virol.8, 419–427 (1998).
  • Pfeffer M, Wernery U, Kaaden OR, Meyer H. Diagnostic procedures for poxvirus infections in camelids. J. Camel Pract. Res.5(2), 189–195 (1998).
  • Wernery U. Viral infections in camels – a review. J. Camel Pract. Res.2(1), 1–12 (1995).
  • Munz E, Otterbein CK, Meyer H, Renner I. A laboratory investigation to demonstrate a decreased virulence of two cell culture adapted African camelpox virus isolates as possible vaccine candidates. J. Camel Prac. Res.4, 169–175 (1997).
  • Czerny CP, Meyer H, Mahnel H. Establishment of an ELISA for the detection of orthopoxviruses based on neutralizing monoclonal and polyclonal antibodies. J. Vet. Med. B Infect. Dis. Vet. Public Health36, 537–546 (1989).
  • Johann S, Czerny CP. A rapid antigen-capture ELISA for the detection of orthopoxviruses. J. Vet. Med. [B]40, 569–581 (1993).
  • Balamurugan V, Bhanuprakash V, Hosamani M et al. A polymerase chain reaction strategy for the diagnosis of camelpox. J. Vet. Diagn. Invest.21(2), 231–237 (2009).
  • Sadykov RG. Cultivation of camelpox virus in chick embryos. In: Virusnye Bolezni Selskokhozayaystvennykh Zhivotnykh, Part I. Moscow, 55 (1970) (In Russian).
  • Tantawi HH, EI-Dahaby H, Fahmy LS. Comparative studies on poxvirus strains isolated from camels. Acta Virol.22, 451–457 (1978).
  • El-Kenawy A, Abdel-Galil Y, El-Mekkawi M, Enany M. Studies on camel pox virus isolated from camels in Sharkia govemorate. J. Egyptian Vet. Med. Assoc.49, 389–395 (1989).
  • Marodam V, Nagendrakumar SB, Tanwar VK et al. Isolation and identification of camelpox virus. Indian J. Animal Sci.76, 326–327 (2006).
  • Marennikova SS. The results of examinations of wildlife monkeys for the presence of antibodies and viruses of the pox group. Vopr. Virusol.3, 321–326 (1975).
  • Schgal CL. Camelpox. In: Report of Summer Institute on Animal Poxviruses. GB Pant University of Agriculture and Technology, India, 161–163 (1977).
  • Boulther EA, Zwartouw HT, Titmuss DH, Maber HB. The nature of the immune state produced by inactivated vaccinia virus in rabbits. Am. J. Epidem.94, 612–618 (1971).
  • Marennikova SS, Malceva NN, Habahpaseva NA. ELISA – a simple test for detecting and differentiating antibodies to closely related orthopoxviruses. Bull. World Health Organ.59, 365–369 (1981).
  • Munz E, Schillinger D, Reimann M, Mahnel H. Electron microscopical diagnosis of Ecthyma contagiosum in camels (Camelus dromedarius): first report of the disease in Kenya. J. Vet. Med. B.33, 73–77 (1986).
  • Munz E, Moallin AS, Mahnel H, Reimann M. Camel papillomatosis in Somalia. Zbl. Vet. B.37, 191–196 (1990).
  • Pfahler WHE, Reimann M, Munz E. A bitoin-avidin amplified enzyme immunoassay for detection and quantitation of orthopox virus camel antibodies in dromedaries. J. Vet. Med. B.33, 477–484 (1986).
  • Arita M, Tagaya I. Structural polypeptides of several strains of orthopoxvirus. Microbiol. Immun.21, 343–346 (1977).
  • Esposito JJ, Obijeski JF, Nakano JH. The virion and soluble antigen proteins of variola, monkeypox and vaccinia viruses. J. Med. Virol.1, 95–110 (1977).
  • November FJ, Raska K Jr, Holowczak JA. The immune response to vaccinia virus infection in mice: analysis of the role of antibody. Arch. Virol.107, 273–289 (1989).
  • Gubser C, Goodbody R, Ecker A et al. Camelpox virus encodes a Schlafen-like protein that affects orthopoxvirus virulence. J. Gen. Virol.88(6), 1667–1676 (2007).
  • Sullivan JT, Mercer AA, Fleming SB, Robinson AJ. Identification and characterization of an orf virus homologue of the vaccinia virus gene encoding the major envelope protein p37K. Virology202, 471–478 (1994).
  • Meyer H, Pfeffer M, Rziha HJ. Sequence alterations within and downstream of the A-type inclusion protein genes allow differentiation of Orthopoxvirus species by polymerase chain reaction. J. Gen. Virol.75, 1975–1981 (1994).
  • Damaso CR, Esposito JJ, Condit RC, Moussatche N. An emergent poxvirus from humans and cattle in Rio de Janeiro state: Cantagalo virus may derive from Brazilian small pox vaccine. Virology277, 439–449 (2000).
  • Lapa S, Mikheev M, Shchelkunov S et al. Species-level identification of orthopoxviruses with an oligonucleotide. Microchip J. Clin. Microbiol.40, 753–757 (2002).
  • Sahay B. Evalugation of gene silencing by RNA interference (RNAi) in control of animal virus infections. PhD thesis. Deemed University, IVRI, Izatnagar, India (2006).
  • Khalafalla AI, Buttner M, Rziha HJ. Polymerase chain reaction (PCR) for rapid diagnosis and differentiation of para- and orthopox virus infections in camels. FAO/IAEA International Animal Production and Health in Developing Countries, 6–10 October 2003, Vienna, Austria (2003).
  • Ropp SL, Jin Q, Knight JC, Massung RF, Esposito JJ. PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J. Clin. Microbiol.33, 2069–2076 (1995).
  • Huemer HP, Honlinger B, Hopfl R. A simple restriction fragment PCR approach for discrimination of human pathogenic old world animal orthopoxvirus species. Can. J. Microbiol.54, 159–162 (2008).
  • Panning M, Asper M, Kramme S, Schmitz H, Drosten C. Rapid detection and differentiation of human pathogenic orthopox viruses by a fluorescence resonance energy transfer real-time PCR assay. Clin. Chem.50, 702–708 (2004).
  • Nitsche A, Ellerbrok H, Pauli, G. Detection of orthopoxvirus DNA by real-time PCR and variola virus DNA by melting analysis. J. Clin. Microbiol.42(3), 1207–1213 (2004).
  • De Clercq E. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. Clin. Microbiol. Rev.14(2), 382–397(2001).
  • Snoeck R, Andrei G, De Clercq E. Therapy of poxvirus infections. In: Poxviruses. Mercer AA, Schmidt A, Weber O (Eds), Birkha¨user, Basel, Switzerland, 375–395 (2007).
  • Sliva K, Schnierle B. From actually toxic to highly specific-novel drugs against poxviruses. Virol. J.4, 8 (2007).
  • Xiong X, Smith JL, Kim C, Huang E, Chen MS. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem. Pharmacol.51, 1563–1567 (1996).
  • Smee DF, Sidwell RW, Kefauver D, Bray M, Huggins JW. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Antimicrob. Agents Chemother.46, 1329–1335 (2002).
  • Andrei G, Gammon DB, Fiten P et al. Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice. J. Virol.80(19), 9391–9401 (2008).
  • Kornbluth RS, Smee DF, Sidwell RW, Snarsky V, Evans DH, Hostetler KY. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. Antimicrob. Agents Chemother.50(12), 4038–4043 (2006).
  • Gammon DB, Snoeck R, Fiten P et al. Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs. J. Virol.82(24), 12520–12534 (2008).
  • Yang G, Pevear DC, Davies MH et al. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge. J. Virol.79(20), 13139–13149 (2005).
  • Berhanu A, King DS, Mosier S et al. ST-246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation. Antimicrob. Agents Chemother.53(12), 4999–5009 (2009).
  • Jordan R, Tien D, Bolken TC et al. Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor. Antimicrob Agents Chemother.52(5), 1721–1727 (2008).
  • Grosenbach DW, Jordan R, King DS et al. Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination. Vaccine26(7), 933–946 (2008).
  • Quenelle DC, Prichard MN, Keith KA et al. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses, Antimicrob. Agents Chemother.51(11), 4118–4124 (2007).
  • Samartsev AA, Praksein ST. Camelpox study. Proc. Kazakh. Res.Vet. Institute5, 198–200 (1950).
  • Buchnev KN, Sadykov RG. Contribution to the study of camelpox. Proceedings of the 3rd All-Union Conference on Virology, Part II, 152–153 (1967).
  • Sedov VA. Official communication: measure for the prevention and eradication of camelpox. Veterinariya (Moscow)44, 295 12, 63–64 (1974).
  • Krupenko SS. Camelpox caused by vaccinia virus. Veterinariya (Moscow) No.8, 61–62 (Ru) (1973).
  • Higgins AJ. The camel in health and disease. Bailliere Tindall, London, UK, 168 (1986).
  • Mayr A, Eissner G, Mayr-Bibrack B. Handbuch der Schutzimpfungen in der Tiermedizin. Paul Parey, Berlin, Germany, 739 (1984).
  • Mayr A. Geschichtlicher Uberblick uberdie Menschenpocken (Variola), die Eradikation von Variola und den attenuierten Pockenstamm MVA. Berl. Munch. Tierarzil. Wschr.112, 322–328 (1999).
  • EL-Harrak M, Loutfi C, Bertin F. Isolement et identification du virus de la variole du dromadaire au Maroc. Ann. Rech. Vet.22, 95–98 (1991).
  • EL-Harrak M. Isolation of camlepox virus, development of an inactivated vaccine and prophylactic application in Morocco. Presented at: Ins. Meeting on Camel Production and Future Perspectives. Al Ain, UAE, May 2–3, 736 (1998).
  • Wernery U, Kaaden OR. Infectious diseases of camels. Blackwell Scientific, Oxford, UK (1995).
  • Wernery U, Kinne J, Zachariah R. Experimental camelpox infection in vaccinated and unvaccinated guanacos, J. Camel Pract. Res.7(2), 149–152 (2000).
  • Klopries M. Etablierung und Charakterisierung einer Kamelhautzellinie (Dubca). Vet. Med. Dissertation Munchen, Germany (1993).
  • Kaaden OR, Wernery U, Klopries M. Camel fibroblast cell line Dubca and its use for diagnosis and prophylaxis of camel diseases. Presented at: The International Conference on Livestock Production in Hot Climates. Muscat, Oman, A49 (1995).
  • De Clercq E. Cidofovir in the treatment of poxvirus infections. Antivir. Res.55, 1–13 (2002).
  • Bera BC, Gnanavel V, Barua S et al. Zoonotic camelpox infections in India. Abstract: International Conference on ‘Protecting Animal Health: Facilitating Trade in Livestock and Livestock Products’ IAVMI, India, January 27–29, 197 (2010).
  • Funahashi S, Sato T, Shida H. Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus. J. Gen. Virol.69, 35–47 (1988).
  • Meyer H, Rziha HJ. Characterization of the gene encoding the A-type inclusion protein of camelpox virus and sequence comparison with other orthopoxviruses. J. Gen. Virol.74, 1679–1684 (1993).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.